JP5325882B2 - 治療用化合物 - Google Patents

治療用化合物 Download PDF

Info

Publication number
JP5325882B2
JP5325882B2 JP2010519260A JP2010519260A JP5325882B2 JP 5325882 B2 JP5325882 B2 JP 5325882B2 JP 2010519260 A JP2010519260 A JP 2010519260A JP 2010519260 A JP2010519260 A JP 2010519260A JP 5325882 B2 JP5325882 B2 JP 5325882B2
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
optionally substituted
compound according
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010519260A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010535203A5 (enExample
JP2010535203A (ja
Inventor
エドモンド ジェイ． ラボイエ，
ジョセフ イー． ライス，
サティアナラヤナ マバラプ，
Original Assignee
ラトガーズ， ザ ステイト ユニバーシティ オブ ニュー ジャージー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ラトガーズ， ザ ステイト ユニバーシティ オブ ニュー ジャージー filed Critical ラトガーズ， ザ ステイト ユニバーシティ オブ ニュー ジャージー
Publication of JP2010535203A publication Critical patent/JP2010535203A/ja
Publication of JP2010535203A5 publication Critical patent/JP2010535203A5/ja
Application granted granted Critical
Publication of JP5325882B2 publication Critical patent/JP5325882B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01M—CATCHING, TRAPPING OR SCARING OF ANIMALS; APPARATUS FOR THE DESTRUCTION OF NOXIOUS ANIMALS OR NOXIOUS PLANTS
    • A01M29/00—Scaring or repelling devices, e.g. bird-scaring apparatus
    • A01M29/16—Scaring or repelling devices, e.g. bird-scaring apparatus using sound waves
    • A01M29/18—Scaring or repelling devices, e.g. bird-scaring apparatus using sound waves using ultrasonic signals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Insects & Arthropods (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2010519260A 2007-08-02 2008-08-01 治療用化合物 Expired - Fee Related JP5325882B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95366007P 2007-08-02 2007-08-02
US60/953,660 2007-08-02
PCT/US2008/072023 WO2009018549A1 (en) 2007-08-02 2008-08-01 Therapeutic compounds

Publications (3)

Publication Number Publication Date
JP2010535203A JP2010535203A (ja) 2010-11-18
JP2010535203A5 JP2010535203A5 (enExample) 2012-09-13
JP5325882B2 true JP5325882B2 (ja) 2013-10-23

Family

ID=40304925

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010519260A Expired - Fee Related JP5325882B2 (ja) 2007-08-02 2008-08-01 治療用化合物

Country Status (5)

Country Link
US (1) US8729060B2 (enExample)
EP (1) EP2183256A4 (enExample)
JP (1) JP5325882B2 (enExample)
MX (1) MX2010001304A (enExample)
WO (1) WO2009018549A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8093235B2 (en) 2006-04-25 2012-01-10 Rutgers, The State University Of New Jersey Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
MX2010001303A (es) 2007-08-02 2010-09-07 Univ Rutgers Compuestos terapeuticos.
US8796300B2 (en) 2009-11-05 2014-08-05 Rutgers, The State University Of New Jersey Therapeutic compounds
BR112013029927A2 (pt) * 2011-05-26 2016-11-29 Novobiotic Pharmaceuticals Llc "compostos antibióticos, composições farmacêuticas, usos das referidas composições e métodos de produção dos referidos compostos".
WO2020017624A1 (ja) * 2018-07-20 2020-01-23 国立大学法人東京農工大学 抗がん剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1253458C (zh) * 2000-12-12 2006-04-26 壮生株式会社 物质gm－95的制备方法
JP4876220B2 (ja) * 2005-05-13 2012-02-15 国立大学法人東京農工大学 テロメスタチン誘導体
US8093235B2 (en) * 2006-04-25 2012-01-10 Rutgers, The State University Of New Jersey Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
MX2010001303A (es) 2007-08-02 2010-09-07 Univ Rutgers Compuestos terapeuticos.

Also Published As

Publication number Publication date
EP2183256A1 (en) 2010-05-12
WO2009018549A1 (en) 2009-02-05
US8729060B2 (en) 2014-05-20
MX2010001304A (es) 2010-09-07
EP2183256A4 (en) 2011-09-28
JP2010535203A (ja) 2010-11-18
US20110230531A1 (en) 2011-09-22

Similar Documents

Publication Publication Date Title
WO2022268230A1 (zh) 作为kif18a抑制剂的化合物
ES2991287T3 (es) Compuestos derivados del 1,3,4-oxadiazol como inhibidor de la histona 6 desacetilasa, y la composición farmacéutica que comprende los mismos
CN114728177B (zh) 作为Kv1.3钾Shaker通道阻滞剂的芳基杂二环化合物
JP2010535203A (ja) 治療用化合物
CN101558074A (zh) 作为抗癌药的在c12-c13位被修饰的埃博霉素类似物
US6903133B2 (en) Anticancer compounds
JP2010535204A (ja) 治療用化合物
WO2002002550A1 (en) Novel pyrazinone derivatives
JP5662940B2 (ja) 新規な抗微生物薬
US8518928B2 (en) Therapeutic compounds
US8796300B2 (en) Therapeutic compounds
CA2665818A1 (en) Therapeutic compounds
CN113439084B (zh) 倍癌霉素类似物
CN110997641A (zh) 新的白纹黄单胞菌毒素衍生物、其用途及合成
EP4077283A1 (en) Progranulin modulators and methods of using the same
EP1793823A2 (en) Sulfonyl hydrazines as hypoxia-selective antineoplastic agents
CN104583203B (zh) Schweinfurthin类似物
KR20020038817A (ko) 암 치료를 위한 항세포증식제로서의 치환 피롤
EP3498712B1 (en) Spirocyclic indolone polyethylene glycol carbonate compound, composition, preparation method and use thereof
CN103450164B (zh) 格尔德霉素衍生物及其制备方法和用途
WO2025199438A1 (en) 7-azaindazole macrocycles and their use
WO2026013255A1 (en) Antagonist heterocyclic compounds involved in the cgas/sting route
WO1997010245A1 (en) 2-[2-[(2-HYDROXYETHYL)AMINO]ETHYL]-5-[[2-METHYLAMINO)ETHYL]AMINO]INDAZOLO[4,3-gh]ISOQUINOLIN-6(2H)-ONE AS ANTITUMOR AGENT
JP2020526529A (ja) 癌の治療のためのエングレリン誘導体
JPWO2002002550A1 (ja) 新規ピラジノン誘導体

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110801

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110801

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120719

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130626

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130627

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130722

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees